JAK-IN-3 is a novel and potent JAK inhibitor with immuomodulatory (anti-inflammatory and anti-RA) activity. It inhibits JAK3, JAK1, TYK2 and JAK2 with IC50 values of 3 nM, 5 nM, 34 nM and 70 nM, respectively.
Physicochemical Properties
| Molecular Formula | C18H20N4O3 |
| Molecular Weight | 340.38 |
| Exact Mass | 340.153 |
| CAS # | 1400876-94-9 |
| PubChem CID | 68291755 |
| Appearance | Light brown to brown solid powder |
| LogP | 1.2 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 6 |
| Heavy Atom Count | 25 |
| Complexity | 458 |
| Defined Atom Stereocenter Count | 2 |
| SMILES | [C@H](NC1C2N(C=C(C3=CC=CC=C3)C=2)N=CC=1C(N)=O)([C@H](O)C)CO |
| InChi Key | PRWQQLFMBINSAW-IAQYHMDHSA-N |
| InChi Code | InChI=1S/C18H20N4O3/c1-11(24)15(10-23)21-17-14(18(19)25)8-20-22-9-13(7-16(17)22)12-5-3-2-4-6-12/h2-9,11,15,21,23-24H,10H2,1H3,(H2,19,25)/t11-,15-/m1/s1 |
| Chemical Name | 4-[[(2R,3R)-1,3-dihydroxybutan-2-yl]amino]-6-phenylpyrrolo[1,2-b]pyridazine-3-carboxamide |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| References |
[1]. Discovery of a JAK1/3 Inhibitor and Use of a Prodrug To Demonstrate Efficacy in a Model of Rheumatoid Arthritis. ACS Med Chem Lett. 2019 Feb 13;10(3):306-311. |
Solubility Data
| Solubility (In Vitro) | DMSO : ~62.5 mg/mL (~183.62 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (6.11 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.9379 mL | 14.6895 mL | 29.3789 mL | |
| 5 mM | 0.5876 mL | 2.9379 mL | 5.8758 mL | |
| 10 mM | 0.2938 mL | 1.4689 mL | 2.9379 mL |